p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cancer Research

• Publication date

  2001-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11479205
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of 11 germline inactivating TP53 mutations and absence of TP63 andHCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome

  2001cited by this paper
• p53 Down-Regulates CHK1 through p21 and the Retinoblastoma Protein

  2001cited by this paper
• A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families

  2001cited by this paper
• Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites

  2001cited by this paper
• Characterization of Tumor-associated Chk2 Mutations*

  2001cited by this paper
• Histological type-selective, tumor-predominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancer.

  2000cited by this paper
• hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response

  2000cited by this paper
• Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.

  2000cited by this paper
• Screening hCHK2 for mutations.

  2000cited by this paper
• Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients?

  2000cited by this paper
• The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.

  2000cited by this paper
• BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.

  2000cited by this paper
• Basis for the Checkpoint Signal Specificity That Regulates Chk1 and Cds1 Protein Kinases

  1999cited by this paper
• Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.

  1999cited by this paper
• Control of the DNA damage checkpoint by chk1 and rad53 protein kinases through distinct mechanisms.

  1999cited by this paper
• CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers.

  1999cited by this paper
• IARC p53 mutation database: A relational database to compile and analyze p53 mutations in human tumors and cell lines

  1999cited by this paper
• Familial endometrial cancer in female carriers of MSH6 germline mutations

  1999cited by this paper
• Role of Human Cds1 (Chk2) Kinase in DNA Damage Checkpoint and Its Regulation by p53*

  1999cited by this paper
• CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers

  1999cited by this paper
• Rad53 FHA domain associated with phosphorylated Rad9 in the DNA damage checkpoint.

  1998cited by this paper
• Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1

  1998cited by this paper
• Linkage of ATM to cell cycle regulation by the Chk2 protein kinase.

  1998cited by this paper
• Evidence of founder mutations in Finnish BRCA1 and BRCA2 families.

  1998cited by this paper
• Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25.

  1997cited by this paper
• Third international workshop on collaborative interdisciplinary studies of p53 and other predisposing genes in Li-Fraumeni syndrome.

  1997cited by this paper
• A low proportion of BRCA2 mutations in Finnish breast cancer families.

  1997cited by this paper
• Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

  1997cited by this paper
• Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.

  1997cited by this paper
• BRCA2 germline mutations in male breast cancer cases and breast cancer families

  1996cited by this paper
• p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.

  1995cited by this paper
• Cell cycle control and cancer.

  1994cited by this paper
• Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.

  1994cited by this paper
• Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes.

  1993cited by this paper
• A cancer family syndrome in twenty-four kindreds.

  1988cited by this paper

• Case report: A germline CHEK1 c.613 + 2T>C leads to a splicing error in a family with multiple cancer patients.

  2024cites this paper
• Li-Fraumeni syndrome presenting with de novo TP53 mutation, severe phenotype and advanced paternal age: a case report

  2024cites this paper
• Association between missense variants of uncertain significance in the CHEK2 gene and hereditary breast cancer: a cosegregation and bioinformatics analysis

  2024cites this paper
• The Prevalence of CHEK1 and CHEK2 Mutations in Prostate Cancer: a Retrospective Cohort Study

  2023cites this paper
• Cancer Predisposition Syndromes and Thyroid Cancer: Keys for a Short Two-Way Street

  2023cites this paper
• Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients

  2022cites this paper
• Minor Kinases with Major Roles in Cytokinesis Regulation

  2022cites this paper
• Healthcare Prometrics in the Era of Redeployment

  2021cites this paper
• Healthcare Prometrics in the Era of Redeployment

  2021cites this paper
• Importancia del síndrome de Li-Fraumeni, un síndrome genético de predisposición al cáncer

  2021cites this paper
• Germline Mutation Analysis in Sporadic Breast Cancer Cases With Clinical Correlations

  2021cites this paper
• Genetic syndromes predisposing to pediatric brain tumors.

  2021cites this paper
• The importance of Li-Fraumeni syndrome, a hereditary cancer predisposition disorder.

  2021cites this paper
• Germline risk of clonal haematopoiesis

  2021cites this paper
• Association of rare variants with familial breast cancer

  2020cites this paper
• Identification of High risk nsSNPs in Human TP53 Gene Associated with Li–Fraumeni Syndrome: An In Silico Analysis Approach

  2020cites this paper
• Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?

  2020cites this paper
• Next‐generation sequencing revealing TP53 mutation as potential genetic driver in dermal deep‐seated melanoma arising in giant congenital nevus in adult patients: A unique case report and review of the literature

  2020cites this paper
• Cancer Predisposition Syndromes Associated With Pediatric High-Grade Gliomas

  2020cites this paper
• Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma

  2019cites this paper
• Review: Ewing Sarcoma Predisposition

  2019cites this paper
• Molecular profile of tongue cancer in an 18‐year‐old female patient with no recognizable risk factor

  2019cites this paper
• An update on the central nervous system manifestations of Li–Fraumeni syndrome

  2019cites this paper
• GENETIC COUNSELING APPROACHES TO MODERATE-PENETRANCE BREAST CANCER GENES

  2019cites this paper
• Li–Fraumeni syndrome heterogeneity

  2019cites this paper
• Homozygosity for CHEK2 p.Gly167Arg leads to a unique cancer syndrome with multiple complex chromosomal translocations in peripheral blood karyotype

  2019cites this paper
• Mutant p53 proteins alter signaling pathways involved in autophagy and redox regulation in cancer cells

  2017cites this paper
• Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline CHEK2:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinoma

  2017cites this paper
• Case report of a Li–Fraumeni syndrome-like phenotype with a de novo mutation in CHEK2

  2016cites this paper
• Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil

  2016cites this paper
• Genotype-Phenotype Analysis in an Indian Family Affected with Li-Fraumeni Syndrome-Role of Genetic Counselling

  2016cites this paper
• Germline Mutations in CHEK1 and CHEK2 in Women with Ovarian, Peritoneal, or Fallopian Tube Cancer

  2015cites this paper
• Rare diseases in clinical endocrinology: a taxonomic classification system

  2015cites this paper
• Etiologic, environmental and inherited risk factors in sarcomas

  2015cites this paper
• Epigenetic alterations in sporadic and familial cancers

  2015cites this paper
• A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk

  2015cites this paper
• First evidence of a large CHEK2 duplication involved in cancer predisposition in an Italian family with hereditary breast cancer

  2014cites this paper
• Kaposi Sarcoma Herpes Virus Latency Associated Nuclear Antigen Protein Release the G2/M Cell Cycle Blocks by Modulating ATM/ATR Mediated Checkpoint Pathway

  2014cites this paper
• The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations

  2014cites this paper
• Chapter 1 p 53 and Hereditary Cancer

  2014cites this paper
• p53 and hereditary cancer.

  2014cites this paper
• TP53 Germline Mutations: Genetics of Li–Fraumeni Syndrome

  2013cites this paper
• The risk of gastric cancer in carriers of CHEK2 mutations

  2013influential citation
• Causes of genome instability.

  2013cites this paper
• Genetic Counseling for TP53 Germline Mutations

  2013cites this paper
• Genetic factors in childhood cancer. Associations between tumors in childhood and adulthood, and prevalence of germline TP53 mutations

  2012cites this paper
• The Role of Tumor Protein 53 Mutations in Common Human Cancers and Targeting the Murine Double Minute 2–P53 Interaction for Cancer Therapy

  2012cites this paper
• CHEK2 1100DELC germline mutation: a frequency study in hereditary breast and colon cancer Brazilian families.

  2012cites this paper
• The CHEK2 I157T variant and colorectal cancer susceptibility: a systematic review and meta-analysis.

  2012cites this paper
• The Study Group on Hereditary Breast and Colorectal Cancer

  2012cites this paper
• The CHEK2 I157T variant and breast cancer susceptibility: a systematic review and meta-analysis.

  2012cites this paper
• Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility.

  2011cites this paper
• Pathology of hereditary breast cancer

  2011cites this paper
• Faithful DNA Replication Requires Regulation of CDK Activity by Checkpoint Kinases

  2011cites this paper
• Familial Gliomas: Role of TP53 Gene

  2011cites this paper
• CHEK2 (CHK2 checkpoint homolog (S. pombe))

  2011cites this paper
• Epidemiology of Breast Cancer

  2011cites this paper
• Early occurrence of lung adenocarcinoma and breast cancer after radiotherapy of a chest wall sarcoma in a patient with a de novo germline mutation in TP53

  2011cites this paper
• Weichgewebesarkome im Rahmen genetischer Syndrome

  2011cites this paper
• Li-fraumeni syndrome.

  2011cites this paper
• Pathology of hereditary breast cancer

  2011cites this paper
• BRCA/Fanconi anemia pathway genes in hereditary predisposition to breast cancer

  2011cites this paper
• Cytogenetic analysis of a malignant triton tumour by comparative genomic hybridization (CGH) and review of the literature

  2011cites this paper
• Genetic analysis of the PI3k/AKT/mTOR signaling pathway

  2010cites this paper
• Association of rare MSH6 variants with familial breast cancer

  2010cites this paper
• Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome

  2010cites this paper
• Molecular Markers in Diagnostic Paediatric Bone Lesions

  2010cites this paper
• Defective autophagy control by the p53 rheostat in cancer

  2010cites this paper
• Chk2 splice variants express a dominant-negative effect on the wild-type Chk2 kinase activity.

  2010cites this paper
• Marijke WasielewskiMuhammad RiazJoyce VermeulenAns van den Ouweland • Ineke Labrijn-MarksRenske OlmerLinda van der SpaaJan G. M. Klijn • Hanne Meijers-HeijboerDennis DooijesMieke Schutte

  2010cites this paper
• Genetic Susceptibility and High Risk Groups for Pancreatic Cancer

  2010cites this paper
• [Li Fraumeni syndrome: a case with multiple primary cancers and presenting a germline p53 mutation].

  2010cites this paper
• Li-Fraumeni syndrome, clinical and molecular genetics

  2010cites this paper
• Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer families

  2010cites this paper
• Architecture of inherited susceptibility to common cancer

  2010cites this paper
• Genetische Veränderungen bei Weichteilsarkomen

  2009cites this paper
• Advances in the genetics of glioblastoma: are we reaching critical mass?

  2009cites this paper
• Hereditary breast cancer syndromes and clinical implications.

  2009cites this paper
• Syndrome de Li-Fraumeni

  2009cites this paper
• The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype

  2009cites this paper
• Novel oncogene amplifications in tumors from a family with Li–Fraumeni syndrome

  2009cites this paper
• Li-Fraumeni syndrome: the genetics and treatment considerations for the sarcoma and associated neoplasms.

  2009cites this paper
• p53: a molecular marker for the detection of cancer.

  2008cites this paper
• Molecular mechanisms of cancer predisposition in HNPCC/Lynch syndrome

  2008cites this paper
• Contribution of the DNA binding domain of p53 to regulation of its stability

  2008cites this paper
• Germline mutations in the CHEK2 kinase gene are associated with an increased risk of bladder cancer

  2008cites this paper
• The Anti-Proliferative Effects of the CHFR Depend on the Forkhead Associated Domain, but not E3 Ligase Activity Mediated by Ring Finger Domain

  2008cites this paper
• Molecular basis of the Li–Fraumeni syndrome: an update from the French LFS families

  2008cites this paper
• Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.

  2008cites this paper
• Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer.

  2008cites this paper
• The analysis of novel gene targets in breast cancer in women ≤35 years.

  2008cites this paper
• Differential cancer predisposition in Lynch syndrome: insights from molecular analysis of brain and urinary tract tumors.

  2008cites this paper
• Alterations of Chk1 and Chk2 expression in colon cancer

  2008cites this paper
• The anti-proliferative effects of the CHFR depend on the forkhead associated domain, but not E3 ligase activity activity mediated by ring finger domain

  2008cites this paper
• CHEK 2 in Breast and Colorectal Cancer

  2007influential citation
• Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromes.

  2007cites this paper
• Deciphering molecular mechanisms that regulate programmed cell death of primordial germ cells in Drosophila melanogaster

  2007cites this paper
• Analysis of Chk2, ATM, NBS1, three proteins involved in the cellular response to DNA damage

  2007cites this paper
• Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?

  2007cites this paper
• Selected aspects of inherited susceptibility to prostate cancer and tumours of different site of origin

  2007cites this paper